Ipsen and Biomunex Pharmaceuticals announced an exclusive global licensing agreement for BMX-502. BMX-502 is a
Eli Lilly and Company announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial.
Takeda announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. to further
Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop
Novartis announced that it has entered into a global license and collaboration agreement with PTC Therapeutics for
Johnson Johnson announced the submission of two supplemental Biologics License Applications (sBLAs) to the
Navidea Biopharmaceuticals, Inc. a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced
Neumora Therapeutics, Inc. announced that the Phase 1 trial of NMRA-266 has been placed on clinical hold by the U.S. Food and Drug Administration
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for the
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically
PepGen Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the
Johnson Johnson announced topline results from the pivotal Phase 3 VIVACITY study of nipocalimab in adults living with generalized myasthenia

health 2 delivery

Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.

The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men

Merck, a leading science and technology company, has launched its M-Trace Software Mobile App, a
Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to
Biogen Inc. and Neomorph Inc. announced a research collaboration to discover and develop molecular glue degraders
AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop
AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and
NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to
Charles River Laboratories International, Inc. and Captain T Cell, a spinoff from the renowned Max Delbrück Center
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that
Astraveus SAS, the creator of modular, microfluidic cell foundries that transform cell and gene therapy (CGT)
Samsung Biologics and Kurma Partners announced a strategic partnership for the development and manufacturing of
Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO
Astellas Pharma Inc. announced its intention to submit a planning application to build a new state-of-the-art
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to
Kesin Pharma Corporation, a pharmaceutical company focused on innovative Specialty brands and Unit Dose
Regeneron Pharmaceuticals, Inc. and Decibel Therapeutics, Inc., a clinical-stage biotechnology company dedicated to
Ionis Pharmaceuticals, Inc. announced that it has entered a collaboration and license agreement with Novartis for
Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that its partner, Gaelan Medical LLC, a
About Us

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts Ipsen and Biomunex announce exclusive global licensing agreement for first-in-class MAIT cell engager in immuno-oncology
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLearn More